IPO registrations (S-1, F-1) · Registrants
Sonnet BioTherapeutics Holdings, Inc.
- SEC CIK
- 1106838 · filings on EDGAR ↗
- Former names
- Chanticleer Holdings, Inc. (2005–2020); TULVINE SYSTEMS INC (2000–2005)
- Registration
- Form S-1, first filed 2011-01-06, last 2025-01-30; 13 initial registrations, 32 amendments
- Outcome
- Final prospectus filed 2011-07-14; declared effective 2011-07-14
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 100 OVERLOOK CENTER, SUITE 102, Princeton, NJ 08540
- EIN
- 52-2102141
- EDGAR entity type
- operating
- Insiders and CEO pay
- Sonnet BioTherapeutics Holdings, Inc. on the corporate pages
On this site
- Form D issuer: Sonnet BioTherapeutics Holdings, Inc. EXACT (CIK (EXACT))
- SEC filer: Chanticleer Holdings, Inc. EXACT (CIK (EXACT))
Filings 113
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2011-01-06 | S-1 | S-1 (registration) | Chanticleer Holdings, Inc. | 0001144204-11-001019 ↗ |
| 2011-06-13 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-11-035326 ↗ |
| 2011-07-13 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-11-040242 ↗ |
| 2011-07-13 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-11-040381 ↗ |
| 2011-07-14 | 424B4 | 424B4 (final prospectus) | Chanticleer Holdings, Inc. | 0001144204-11-040588 ↗ |
| 2011-07-14 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-11-002128 ↗ |
| 2011-12-02 | S-1 | S-1 (registration) | Chanticleer Holdings, Inc. | 0001144204-11-068208 ↗ |
| 2011-12-08 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-11-069036 ↗ |
| 2012-02-03 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-12-005708 ↗ |
| 2012-02-22 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-12-010342 ↗ |
| 2012-04-12 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-12-021294 ↗ |
| 2012-05-21 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-12-030724 ↗ |
| 2012-05-30 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-12-032581 ↗ |
| 2012-06-05 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-12-033293 ↗ |
| 2012-06-19 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-12-035362 ↗ |
| 2012-06-19 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-12-035462 ↗ |
| 2012-06-20 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-12-001888 ↗ |
| 2012-06-21 | 424B4 | 424B4 (final prospectus) | Chanticleer Holdings, Inc. | 0001144204-12-035741 ↗ |
| 2013-05-31 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-13-001676 ↗ |
| 2013-06-04 | 424B4 | 424B4 (final prospectus) | Chanticleer Holdings, Inc. | 0001144204-13-033066 ↗ |
| 2014-01-22 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-14-000178 ↗ |
| 2014-04-17 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-14-001039 ↗ |
| 2015-01-14 | S-1 | S-1 (registration) | Chanticleer Holdings, Inc. | 0001144204-15-002138 ↗ |
| 2015-02-05 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-15-006360 ↗ |
| 2015-02-12 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-15-008074 ↗ |
| 2015-02-17 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001144204-15-009288 ↗ |
| 2015-02-17 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-15-000438 ↗ |
| 2015-04-03 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-15-000783 ↗ |
| 2015-06-09 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-15-001567 ↗ |
| 2015-12-08 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-15-003214 ↗ |
| 2016-10-28 | S-1 | S-1 (registration) | Chanticleer Holdings, Inc. | 0001493152-16-014350 ↗ |
| 2016-11-18 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001493152-16-015248 ↗ |
| 2016-12-05 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001493152-16-015654 ↗ |
| 2016-12-12 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001493152-16-015793 ↗ |
| 2016-12-15 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-16-006461 ↗ |
| 2017-03-17 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-17-000579 ↗ |
| 2017-10-27 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-17-002806 ↗ |
| 2017-12-21 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-17-003288 ↗ |
| 2018-09-05 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-18-002271 ↗ |
| 2019-04-15 | S-1 | S-1 (registration) | Chanticleer Holdings, Inc. | 0001493152-19-005249 ↗ |
| 2019-05-28 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001493152-19-008306 ↗ |
| 2019-06-07 | S-1/A | S-1/A (amendment) | Chanticleer Holdings, Inc. | 0001493152-19-008854 ↗ |
| 2019-06-11 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-19-001326 ↗ |
| 2020-02-11 | EFFECT | EFFECT (declared effective) | Chanticleer Holdings, Inc. | 9999999995-20-000315 ↗ |
| 2020-04-02 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-20-000672 ↗ |
| 2020-07-15 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-20-001807 ↗ |
| 2020-12-29 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-20-003687 ↗ |
| 2021-01-21 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-21-000228 ↗ |
| 2021-06-04 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-21-002209 ↗ |
| 2021-07-22 | S-1 | S-1 (registration) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-21-017534 ↗ |
| 2021-08-03 | S-1/A | S-1/A (amendment) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-21-018454 ↗ |
| 2021-08-16 | S-1/A | S-1/A (amendment) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-21-020251 ↗ |
| 2021-08-19 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-21-003246 ↗ |
| 2021-08-23 | 424B4 | 424B4 (final prospectus) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-21-020999 ↗ |
| 2022-09-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-22-002737 ↗ |
| 2022-09-19 | 424B4 | 424B4 (final prospectus) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-22-026240 ↗ |
| 2023-01-19 | S-1 | S-1 (registration) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-23-001949 ↗ |
| 2023-01-30 | S-1/A | S-1/A (amendment) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-23-002927 ↗ |
| 2023-02-06 | S-1/A | S-1/A (amendment) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-23-003613 ↗ |
| 2023-02-07 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-23-000296 ↗ |
| 2023-02-09 | 424B4 | 424B4 (final prospectus) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-23-004066 ↗ |
| 2023-07-28 | S-1 | S-1 (registration) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-23-025889 ↗ |
| 2023-08-09 | 424B4 | 424B4 (final prospectus) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-23-027371 ↗ |
| 2023-08-09 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-23-002324 ↗ |
| 2023-09-19 | S-1 | S-1 (registration) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-23-033076 ↗ |
| 2023-09-28 | S-1/A | S-1/A (amendment) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-23-034503 ↗ |
| 2023-10-04 | S-1/A | S-1/A (amendment) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-23-035654 ↗ |
| 2023-10-19 | S-1/A | S-1/A (amendment) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-23-037729 ↗ |
| 2023-10-24 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-23-003081 ↗ |
| 2023-10-26 | 424B4 | 424B4 (final prospectus) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-23-038337 ↗ |
| 2024-01-04 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-24-000046 ↗ |
| 2024-05-03 | S-1 | S-1 (registration) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-24-017633 ↗ |
| 2024-05-15 | S-1/A | S-1/A (amendment) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-24-019825 ↗ |
| 2024-05-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-24-001554 ↗ |
| 2024-07-15 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-24-002167 ↗ |
| 2024-10-28 | S-1 | S-1 (registration) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-24-042613 ↗ |
| 2024-11-04 | S-1/A | S-1/A (amendment) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-24-043438 ↗ |
| 2024-11-06 | S-1/A | S-1/A (amendment) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-24-043769 ↗ |
| 2024-11-06 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-24-003395 ↗ |
| 2024-11-07 | 424B4 | 424B4 (final prospectus) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-24-043935 ↗ |
| 2025-01-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-000147 ↗ |
| 2025-01-22 | S-1 | S-1 (registration) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-25-003230 ↗ |
| 2025-01-22 | S-1 | S-1 (registration) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-25-003232 ↗ |
| 2025-01-30 | S-1/A | S-1/A (amendment) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-25-004302 ↗ |
| 2025-01-30 | S-1/A | S-1/A (amendment) | Sonnet BioTherapeutics Holdings, Inc. | 0001493152-25-004303 ↗ |
| 2025-01-31 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-000273 ↗ |
| 2025-01-31 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-000274 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003746 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003747 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003748 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003749 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003751 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003752 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003753 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003754 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003755 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003756 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003758 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003759 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003762 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003763 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003764 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003766 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003767 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003768 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003772 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003773 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003774 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003775 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003777 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003780 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003782 ↗ |
| 2025-12-16 | EFFECT | EFFECT (declared effective) | Sonnet BioTherapeutics Holdings, Inc. | 9999999995-25-003783 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Pruitt Michael D | Director,Officer; Director,Officer,TenPercentOwner | CEO, Chairman; CEO/President; Cheif Executive Officer; Chief Executive Officer; CHIEF EXECUTIVE OFFICER | 84 | 2006–2020 | |
| PALISADES MASTER FUND LP | TenPercentOwner | 26 | 2006–2010 | ||
| PEF ADVISORS LTD | TenPercentOwner | 26 | 2006–2010 | ||
| Johnson Keith J | Director | 3 | 2010–2019 | ||
| ENGLANDER ISRAEL A | Other | 1 | 2012 | ||
| ICS OPPORTUNITIES, LTD. | TenPercentOwner | 1 | 2012 | ||
| MILLENNIUM INTERNATIONAL MANAGEMENT GP LLC | Other | 1 | 2012 | ||
| MILLENNIUM INTERNATIONAL MANAGEMENT LP | Other | 1 | 2012 | ||
| MILLENNIUM MANAGEMENT LLC | Other | 1 | 2012 | ||
| LEDERER ERIC S | Officer | Cheif Financial Officer | 1 | 2012 | |
| PAGE RUSSELL JACOB | Director | 3 | 2013–2019 | ||
| SMITH DARREN HOWARD | Officer | CFO of S. African Subsidiary; CPO of S. African Subsidiary | 3 | 2013–2015 | |
| HOOTERS OF OREGON PARTNERS, L.L.C. | TenPercentOwner | 1 | 2014 | ||
| HOOTERS OF WASHINGTON, L.L.C. | Other | 1 | 2014 | ||
| SPITCAUFSKY LARRY | Director; Director,TenPercentOwner; Other; TenPercentOwnerOther | 10 | 2014–2019 | ||
| Roberson Mark Daniel | Officer | Chief Operating Officer | 3 | 2015–2016 | |
| Carroll J Michael | Director | 2 | 2015–2016 | ||
| ADAMS RICHARD | Other | 3 | 2015–2019 | ||
| MOSKOWITZ PAUL I | Director | 2 | 2015 | ||
| Kraut Gregory Evan | Director | 9 | 2016–2017 | ||
| Porter Paul G | Director | 1 | 2016 | ||
| KIEFER NEIL G | Director | 2 | 2017–2019 | ||
| Glick Frederick L | Officer | President; PRESIDENT | 5 | 2018–2020 | |
| Harkleroad Patrick Clay | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 2 | 2019 | |
| Shadoin Troy Matson | Officer | Chief Accounting Officer; CHIEF ACCOUNTING OFFICER | 2 | 2019 | |
| Wagoner J Eric | Director | 2 | 2019 | ||
| Hersch Robert Sumner | TenPercentOwner | 2 | 2019–2020 | ||
| MV Amanth LLC | TenPercentOwner | 2 | 2019–2020 | ||
| Oz Rey LLC | TenPercentOwner | 2 | 2019–2020 | ||
| Bhatt Nailesh | Director | 9 | 2020–2025 | ||
| Cini John K. | Director; Officer | Chief Scientific Officer | 10 | 2020–2025 | |
| Cross John Harry III | Officer | Chief Financial Officer | 6 | 2020–2024 | |
| Dexter Susan | Director; Officer | Chief Technical Officer | 10 | 2020–2025 | |
| Dyrness Albert D. | Director | 10 | 2020–2025 | ||
| Griffith Donald J. | Director; Director,Officer | Chief Financial Officer | 9 | 2020–2025 | |
| Mohan Pankaj | Director,Officer; Director,Officer,TenPercentOwner | Chairman, President and CEO | 13 | 2020–2024 | |
| Rao Raghu | Director; Director,Officer | Chief Executive Officer; Interim CEO | 9 | 2020–2025 | |
| RUGG TERENCE ANTHONY | Officer | Chief Medical Officer | 2 | 2020 | |
| Kenney Richard T | Officer | Chief Medical Officer | 10 | 2021–2025 | |
| McNeill Lori | Director | 5 | 2022–2025 | ||
| Markey John | TenPercentOwner | 1 | 2023 | ||
| MCANDREW STEPHEN J | Officer | Chief Business Officer | 3 | 2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-12-23 | Sonnet BioTherapeutics Holdings, Inc. | Biotechnology | $3,918,000 | $3,918,000 | 4 | 1 |
| 2023-07-17 | Sonnet BioTherapeutics Holdings, Inc. | Biotechnology | $2,250,000 | $2,250,000 | 1 | 1 |
| 2022-08-19 | Sonnet BioTherapeutics Holdings, Inc. | Biotechnology | $2,250,000 | $2,250,000 | 5 | 1 |
| 2018-05-16 | Chanticleer Holdings, Inc. | Restaurants | $1,411,249 | $1,411,249 | 13 | 1 |
| 2017-05-11 | Chanticleer Holdings, Inc. | Restaurants | $6,000,000 | $6,000,000 | 14 | 1 |
| 2015-03-18 | Chanticleer Holdings, Inc. | Restaurants | $1,000,000 | $1,000,000 | 1 | 1 |
| 2015-01-16 | Chanticleer Holdings, Inc. | Restaurants | $1,150,000 | $1,150,000 | 12 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.